Publication | Closed Access

Association of Cytidine Deaminase and Xeroderma Pigmentosum Group D Polymorphisms with Response, Toxicity, and Survival in Cisplatin/Gemcitabine-Treated Advanced Non-small Cell Lung Cancer Patients

Cytidine DeaminaseOncogenic AgentMedicinePathologyBronchial NeoplasmCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerCancer Research